Pablo Catalá

Protocol for the ELISPOT-TC Trial: A Randomized Controlled Study Evaluating CMV-Specific Cellular Immune Monitoring in Heart Transplant Recipients

Elena García‐Romero, Carles Díez‐López, Delphine Kervella, Víctor Donoso et autres

Memory/effector T cells help control CMV through responses to IE-1 and pp65 antigens and the IFN-γ ELISpot assay enables the detection of CMV-reactive T cells and prediction of infection risk (3). CMV-specific cellular immunity (CMI) can identify higher-risk kidney transplant recipients who …

es (code pays fourni par la source)

Maintenance Immunosuppression With Tacrolimus and Everolimus in Heart Transplantation Compared With the Usual Tacrolimus and Micophenolate Protocol: Results From a Retrospective Registry

María Vigil-Escalera, Pablo Catalá, Vanesa Alonso, Lorena Herrador et autres

es (code pays fourni par la source)

A Novel 8-Predictors Signature to Predict Complicated Disease Course in Pediatric-onset Crohn’s Disease: A Population-based Study

Hélène Sarter, Guillaume Savoye, Guillemette Marot, Delphine Ley et autres

BACKGROUND: The identification of patients at high risk of a disabling disease course would be invaluable in guiding initial therapy in Crohn's disease (CD). Our objective was to evaluate a combination of clinical, serological, and genetic factors to predict complicated disease course …

fr, us (code pays fourni par la source)

Chronic use of renin–angiotensin–aldosterone inhibitors in hypertensive COVID-19 patients: Results from a Spanish registry and meta-analysis

Álvaro Aparisi, Pablo Catalá, Ignacio J. Amat‐Santos, Marta Marcos-Mangas et autres

es (code pays fourni par la source)

Post-COVID-19 syndrome: prospective evaluation of clinical and functional outcomes

Cristina Ybarra Falcón, Álvaro Aparisi, Claudia I. Echeverría, Javier Tobar et autres

Abstract Introduction Coronavirus disease 2019 (COVID-19) is a highly pathogenic coronavirus characterized by by systemic inflammatory response with endothelial damage and a dysregulated coagulation system. Despite most patients survive the acute setting of COVID-19, their long-term clinical sequelae are highly unclear. We …

es (code pays fourni par la source)

1854P Multicentric, comparative, retrospective study on the safety and efficacy of conventional chemotherapy in cirrhotic patients with gastrointestinal cancer

Massih Ningarhari, Marlène Bertez, Anne Ploquin, Nicolas Bertrand et autres

fr (code pays fourni par la source)

Atrial fibrillation in patients with SARS-CoV-2 infection

Pablo Elpidio García-Granja, Carlos Alberto Gurgel Veras, Álvaro Aparisi, Ignacio J. Amat‐Santos et autres

es (code pays fourni par la source)

Exercise Ventilatory Inefficiency in Post-COVID-19 Syndrome: Insights from a Prospective Evaluation

Álvaro Aparisi, Cristina Ybarra-Falcón, Mario Garcia Gomez, Javier Tobar et autres

Introduction: Coronavirus disease 2019 (COVID-19) is a systemic disease characterized by a disproportionate inflammatory response in the acute phase. This study sought to identify clinical sequelae and their potential mechanism. Methods: We conducted a prospective single-center study (NCT04689490) of previously hospitalized COVID-19 …

es (code pays fourni par la source)

Chronic use of renin–angiotensin–aldosterone inhibitors in hypertensive COVID-19 patients: Results from a Spanish registry and meta-analysis

Álvaro Aparisi, Pablo Catalá, Ignacio J. Amat‐Santos, Marta Marcos-Mangas et autres

es (code pays fourni par la source)

The COVID-19 lab score: an accurate dynamic tool to predict in-hospital outcomes in COVID-19 patients

Pablo Antúnez‐Muiños, Diego López‐Otero, Ignacio J. Amat‐Santos, Javier López País et autres

Deterioration is sometimes unexpected in SARS-CoV2 infection. The aim of our study is to establish laboratory predictors of mortality in COVID-19 disease which can help to identify high risk patients. All patients admitted to hospital due to Covid-19 disease were included. Laboratory …

es (code pays fourni par la source)

Impact of the presence of heart disease, cardiovascular medications and cardiac events on outcome in COVID-19

Gonzalo Cabezón Villalba, Ignacio J. Amat‐Santos, Carlos Dueñas, Diego López‐Otero et autres

BACKGROUND: Cardiovascular risk factors and usage of cardiovascular medication are prevalent among coronavirus disease 2019 (COVID-19) patients. Little is known about the cardiovascular implications of COVID-19. The goal herein, was to evaluate the prognostic impact of having heart disease (HD) and taking …

es (code pays fourni par la source)

Atrial fibrillation in patients with SARS-CoV-2 infection

Pablo Elpidio García-Granja, Carlos Alberto Gurgel Veras, Álvaro Aparisi, Ignacio J. Amat‐Santos et autres

es (code pays fourni par la source)